BRIEF — Alar Submits Application To US FDA For Clinical Trial Of ALA — 3000 For Depression

Oct 16 (Reuters) — Alar Pharmaceuticals Inc: Submits Application To Us Fda For Phase Ii Clinical Trial Of Ala-3000 For Depression Treatment Source text:... Further company coverage: (Reporting by Hong Kong newsroom) ((donny.kwok@thomsonreuters.com; +852 3462 7745;)